Reduction of cell viability induced by IFN-alpha generates impaired data on antiviral assay using Hep-2C cells
Authors:
- Edson R.A. de OliveiraEOEdson R.A. de Oliveira
- Bruna M.M.P. LimaBLBruna M.M.P. Lima
- Wlamir C. de MouraWMWlamir C. de Moura
- Ana Cristina M. de A. NogueiraANAna Cristina M. de A. Nogueira
- 1 December 2013
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 400-401, 97-105
Abstract
No abstract availableKeywords
Funding Information
- Fundação Oswaldo Cruz
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Ministério da Educação
This publication has 29 references indexed in Scilit:
- Interferons as Inducers of Apoptosis in Malignant CellsJournal of Interferon & Cytokine Research, 2013
- Potency determination of recombinant IFN-alpha based on phosphorylated STAT1 using flow cytometryJournal of Immunological Methods, 2012
- Type I interferon therapy and its role in autoimmunityAutoimmunity, 2010
- NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulationBritish Journal of Cancer, 2010
- Efficacy of Chronic Hepatitis C Therapy in Community-Based TrialsClinical Gastroenterology and Hepatology, 2009
- Human interferon-λ3 is a potent member of the type III interferon familyGenes & Immunity, 2008
- IFN-α and IFN-λ differ in their antiproliferative effects and duration of JAK/STAT signaling activityCancer Biology & Therapy, 2008
- Interferon-α and cancer: Mechanisms of action and new perspectives of clinical useBiochimie, 2007
- Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosisApoptosis, 2003
- Interferon-? Is More Potent Than Interferon-? in Inhibition of Human Hepatocellular Carcinoma Cell Growth When Used Alone and in Combination With Anticancer DrugsAnnals of Surgical Oncology, 2003